UNSPSC 51172020: Sincalide

Sincalide (INN) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas.

UNSPSC 51172020 Sincalide, a Commodity code, does not reflect the actual scope of state and local procurement activity recently posted under this classification. The single recent opportunity tagged to this code is Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services, which involves immunoassay screening, LC/MS/MS or GC/MS confirmation testing, oral fluid and hair testing alternatives, and staffing of collection sites — work entirely unrelated to sincalide, a pharmaceutical agent used in hepatobiliary imaging. The mismatch suggests either a data-entry error in the county's tagging system or that this code carries little relevant recent state and local procurement activity.

The Collin County RFP, due July 23, 2026, with an estimated contract value of $600,000 and a term of two years plus three optional one-year renewals, remains the only recent state and local opportunity identifiable under this code. Proposals will be evaluated on vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), and optional Phase 2 demonstrations and interviews (up to 30 points). The successful vendor must maintain lab certification from SAMHSA, TX DPS, or CAP and will handle approximately 25,031 annual tests across multiple panel types with no additional surcharges permitted beyond the per-test pricing model. Given the absence of relevant recent opportunities and the clear mismatch between the code's pharmaceutical scope and the actual work being solicited, this code warrants limited pursuit focus for business development purposes.